Počet záznamov: 1
syndróm lýzy nádoru
SYS d015275 LBL 00000nx--j22000003--45-- 005 20240119201241.3 100 $a 19920519csloy0103----ba0 152 $b mesh 250 $a syndróm lýzy nádoru $x BL $x CF $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo 300 1-
$a 89 $8 eng 300 1-
$a Antineoplastic Agents, Combined/adverse effects/therapeutic use (1980-1988) $8 eng 300 1-
$a Antineoplastic Agents/therapeutic use (1984-1988) $8 eng 300 1-
$a Burkitt's Lymphoma/complications (1980-1988) $8 eng 330 1-
$a A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia. $8 eng 550 $3 sllk_un_auth*d000970 $Y Antineoplastic Agents $5 B $a antineoplastiká 550 $3 sllk_un_auth*d014409 $Y Tumor Necrosis Factor-alpha $5 F $a faktor nekrotizujúci nádory, alfa 686 $a C15.604.515.880 686 $a C20.683.515.950 750 $a Tumor Lysis Syndrome $8 eng 801 -0
$a US $b DNLM $c 19920519 801 -2
$a SK $b BA006 $c 20070706 820 $a lymphoproliferative disord caused by anticancer drugs; coord IM with /etiol (not /chem ind) + anticancer drug /adv eff (IM) + required neopl coords /drug ther (IM or NIM) if pertinent $8 eng 980 $x M
Počet záznamov: 1